SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Matria Healthcare (MATR)
MATR 2.680+0.2%Aug 20 5:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: GREATMOOD who wrote (97)12/15/1997 8:31:00 AM
From: GREATMOOD  Read Replies (1) of 220
 
To All:
Matria is accelerating its entry in to the DIABETES MANAGEMENT FIELD. This is one of the developments that should grow revenues going forward.
GM
________________________________________________
Matria Healthcare, Inc. Nasdaq: MATR) Announces Strategic Alliance With Subsidiary of Eli Lilly & Co.

MARIETTA, Ga., Dec. 15 /PRNewswire/ -- MATRIA HEALTHCARE, INC. (Nasdaq: MATR) announced today that it has entered into an agreement with Control Diabetes Services, Inc., a subsidiary of Eli Lilly & Co., to form a strategic, alliance to provide diabetes patient self-management training and education services in nine (9) regions throughout the country. Under the agreement, Matria will be the preferred provider of diabetes education services to Control Diabetes' managed care customers and will have rights to market on its own behalf Control Diabetes' ADA-certified diabetes education program and to use Control Diabetes' unique Dia-Trac(TM) outcome tracking and reporting software. Matria will provide these diabetes services in conjunction with Diabetes Management Services, Inc., a privately held company in which Matria is acquiring a minority ownership interest together with an option to purchase the entire entity.

"We are extremely excited about this alliance in that it permits us to accelerate the expansion of our specialized obstetrical diabetes program as well as provides an entry into the general diabetes population," stated Frank Powers, Executive Vice President and Chief Operating Officer of Matria. In addition to providing services under this arrangement, Matria will continue to offer its own obstetrical diabetes program independently to patients, physicians, employers and third-party payors.

This press release contains forward-looking statements that involve risks and uncertainties, including developments in the healthcare industry, third- party actions over which Matria does not have control, and regulatory requirements applicable to Matria's business, as well as other risks detailed from time to time in Matria's reports filed with the Securities and Exchange Commission.

Matria Healthcare, Inc. is the leading provider of comprehensive obstetrical homecare and maternity management services to HMOs, indemnity carriers, and employers.

SOURCE Matria Healthcare, Inc.

CO: Matria Healthcare, Inc.; Eli Lilly & Co.; Control Diabetes, Inc.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext